Cargando…

Exosome therapeutics for lung regenerative medicine

Exosomes are 30 to 100 nm extracellular vesicles that are secreted by many cell types. Initially viewed as cellular garbage with no biological functions, exosomes are now recognized for their therapeutic potential and used in regenerative medicine. Cell-derived exosomes are released into almost all...

Descripción completa

Detalles Bibliográficos
Autores principales: Popowski, Kristen, Lutz, Halle, Hu, Shiqi, George, Arianna, Dinh, Phuong-Uyen, Cheng, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480570/
https://www.ncbi.nlm.nih.gov/pubmed/32944172
http://dx.doi.org/10.1080/20013078.2020.1785161
_version_ 1783580437912748032
author Popowski, Kristen
Lutz, Halle
Hu, Shiqi
George, Arianna
Dinh, Phuong-Uyen
Cheng, Ke
author_facet Popowski, Kristen
Lutz, Halle
Hu, Shiqi
George, Arianna
Dinh, Phuong-Uyen
Cheng, Ke
author_sort Popowski, Kristen
collection PubMed
description Exosomes are 30 to 100 nm extracellular vesicles that are secreted by many cell types. Initially viewed as cellular garbage with no biological functions, exosomes are now recognized for their therapeutic potential and used in regenerative medicine. Cell-derived exosomes are released into almost all biological fluids, making them abundant and accessible vesicles for a variety of diseases. These naturally occurring nanoparticles have a wide range of applications including drug delivery and regenerative medicine. Exosomes sourced from a specific tissue have been proven to provide greater therapeutic effects to their native tissue, expanding exosome sources beyond traditional cell lines such as mesenchymal stem cells. However, standardizing production and passing regulations remain obstacles, due to variations in methods and quantification techniques across studies. Additionally, obtaining pure exosomes at sufficient quantities remains difficult due to the heterogeneity of exosomes. In this review, we will underline the uses of exosomes as a therapy and their roles in lung regenerative medicine, as well as current challenges in exosome therapies.
format Online
Article
Text
id pubmed-7480570
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-74805702020-09-16 Exosome therapeutics for lung regenerative medicine Popowski, Kristen Lutz, Halle Hu, Shiqi George, Arianna Dinh, Phuong-Uyen Cheng, Ke J Extracell Vesicles Review Article Exosomes are 30 to 100 nm extracellular vesicles that are secreted by many cell types. Initially viewed as cellular garbage with no biological functions, exosomes are now recognized for their therapeutic potential and used in regenerative medicine. Cell-derived exosomes are released into almost all biological fluids, making them abundant and accessible vesicles for a variety of diseases. These naturally occurring nanoparticles have a wide range of applications including drug delivery and regenerative medicine. Exosomes sourced from a specific tissue have been proven to provide greater therapeutic effects to their native tissue, expanding exosome sources beyond traditional cell lines such as mesenchymal stem cells. However, standardizing production and passing regulations remain obstacles, due to variations in methods and quantification techniques across studies. Additionally, obtaining pure exosomes at sufficient quantities remains difficult due to the heterogeneity of exosomes. In this review, we will underline the uses of exosomes as a therapy and their roles in lung regenerative medicine, as well as current challenges in exosome therapies. Taylor & Francis 2020-06-29 /pmc/articles/PMC7480570/ /pubmed/32944172 http://dx.doi.org/10.1080/20013078.2020.1785161 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of The International Society for Extracellular Vesicles. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Popowski, Kristen
Lutz, Halle
Hu, Shiqi
George, Arianna
Dinh, Phuong-Uyen
Cheng, Ke
Exosome therapeutics for lung regenerative medicine
title Exosome therapeutics for lung regenerative medicine
title_full Exosome therapeutics for lung regenerative medicine
title_fullStr Exosome therapeutics for lung regenerative medicine
title_full_unstemmed Exosome therapeutics for lung regenerative medicine
title_short Exosome therapeutics for lung regenerative medicine
title_sort exosome therapeutics for lung regenerative medicine
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480570/
https://www.ncbi.nlm.nih.gov/pubmed/32944172
http://dx.doi.org/10.1080/20013078.2020.1785161
work_keys_str_mv AT popowskikristen exosometherapeuticsforlungregenerativemedicine
AT lutzhalle exosometherapeuticsforlungregenerativemedicine
AT hushiqi exosometherapeuticsforlungregenerativemedicine
AT georgearianna exosometherapeuticsforlungregenerativemedicine
AT dinhphuonguyen exosometherapeuticsforlungregenerativemedicine
AT chengke exosometherapeuticsforlungregenerativemedicine